U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 18,580
-230 (-1.22%)
At close: Apr 9, 2026
546.26% (1Y)
| Market Cap | 294.59B +723.3% |
| Revenue (ttm) | 25.59B +2.2% |
| Net Income | -1.64B |
| EPS | -141.00 |
| Shares Out | 15.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (0.54%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 274,864 |
| Average Volume | 566,666 |
| Open | 18,850 |
| Previous Close | 18,810 |
| Day's Range | 18,190 - 20,500 |
| 52-Week Range | 2,850 - 32,800 |
| Beta | 1.89 |
| RSI | 48.01 |
| Earnings Date | n/a |